Curaleaf Holdings said Tuesday it signed a $286 million definitive agreement to acquire London-based medical marijuana company Emmac Life Sciences, giving the Massachusetts-based multistate operator a major foothold in the European cannabis market and a leg up on rival businesses. The terms of the deal call for Curaleaf to pay $286 million up front, with […]
Curaleaf enters European cannabis market with $286 million acquisition of Emmac Life Sciences is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
Credit:Source link